Reference
Drilon A, et al. Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas. Cancer Discovery 3: 630-635, No. 6, Jan 2013. Available from: URL: http://dx.doi.org/10.1158/2159-8290.CD-13-0035 - USA
Rights and permissions
About this article
Cite this article
Cabozantinib. Reactions Weekly 1461, 12 (2013). https://doi.org/10.1007/s40278-013-4560-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-4560-1